|
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $0.25 | $-0.01 | -103.9% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'25 | $7.7B | $7.8B | +1.2% |
Market Data
MDLN is currently trading at $38.08, giving MDLN a market cap of 58.53B and a P/E ratio of 48.8. Today's range spans $44.03–$45.43, with shares opening at $44.61 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 0/100 (SELL) with a news sentiment reading of 54/100.
Over the past year MDLN has traded between $34.89 and $47.99 - the current price is +9.1% off the 52-week low and -20.7% from the high.
Risk is elevated for MDLN (MDLN) right now - bearish technical setup (0/100, SELL), neutral sentiment (54/100), price $38.08 (in the lower half of its 52-week range). The current P/E ratio stands at 48.8. At 58.53B in Healthcare market cap, the 52-week range of $34.89–$47.99 defines where structural demand might resurface - because at this capitalization tier, buyers don't disappear, they just move their bids to different price levels.
When a large-cap Healthcare name with 58.53B in capitalization prints a SELL signal (0/100) alongside neutral news sentiment (54/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $38.08 (in the lower half of its 52-week range in the $34.89–$47.99 range), the structural support levels are where that sponsorship question gets answered.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines